Literature DB >> 23397233

Clinical and microbiological implications of time-to-positivity of blood cultures in patients with Gram-negative bacilli bacteremia.

H R Palmer1, E L Palavecino, J W Johnson, C A Ohl, J C Williamson.   

Abstract

Time-to-positivity (TTP) is defined as the length of time from the beginning of culture incubation to the detection of bacterial growth by an automated system. The objective of this study was to assess the clinical and microbiological implications of TTP among patients with Gram-negative bacilli (GNB) bacteremia. This was a prospective, single-center, observational study. Patients aged 18 years or older with one or more blood cultures growing GNB were included and followed until hospital discharge or death. Patients were excluded if they were without symptoms of infection, if they had polymicrobial culture, or if the culture was positive with an obligate anaerobe. A multivariate logistic regression analysis was performed to determine the predictors of in-hospital mortality, including TTP (primary endpoint), demographics, disease severity, comorbidities, pathogen type, source of infection, time to symptom resolution, hospital/intensive care unit (ICU) length of stay, adequacy of empiric antibiotics, and presence of an extended-spectrum beta-lactamase (ESBL)-producing bacteria. One hundred consecutive patients with GNB bacteremia were enrolled. TTP was an independent predictor of mortality; for every hour that TTP was shorter, the risk of mortality increased by 10% [odds ratio (OR) 1.10, 95% confidence interval (CI) 1.00-1.21, p = 0.049]. Other predictors of mortality included severity of illness, ESBL-producing GNB, and ICU admission within 24 h before culture. Mortality was highest among patients with inadequate empiric therapy (56% vs. 14%, p < 0.001) and TTP <11 h (23.1% vs. 8.3%, p = 0.18). Lactose-fermenting GNB had a shorter mean TTP than non-lactose fermenters (11.4 vs. 17.9 h, p = 0.001). Among patients with bacteremia due to GNB, TTP values are inversely associated with mortality risk.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23397233     DOI: 10.1007/s10096-013-1833-9

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  10 in total

1.  The use of continuous monitoring blood culture systems in the diagnosis of catheter related sepsis.

Authors:  M S Rogers; B A Oppenheim
Journal:  J Clin Pathol       Date:  1998-08       Impact factor: 3.411

2.  Earlier positivity of central-venous- versus peripheral-blood cultures is highly predictive of catheter-related sepsis.

Authors:  F Blot; E Schmidt; G Nitenberg; C Tancrède; B Leclercq; A Laplanche; A Andremont
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

3.  Time to positivity in Staphylococcus aureus bacteremia: possible correlation with the source and outcome of infection.

Authors:  Riad Khatib; Kathleen Riederer; Sajjad Saeed; Leonard B Johnson; Mohamad G Fakih; Mamta Sharma; M Shamse Tabriz; Amir Khosrovaneh
Journal:  Clin Infect Dis       Date:  2005-07-22       Impact factor: 9.079

4.  Relationship of phylogenetic background, biofilm production, and time to detection of growth in blood culture vials with clinical variables and prognosis associated with Escherichia coli bacteremia.

Authors:  Jose A Martínez; Sara Soto; Anna Fabrega; Manel Almela; Josep Mensa; Alex Soriano; Francesc Marco; María T Jimenez de Anta; Jordi Vila
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

5.  Time to blood culture positivity as a predictor of clinical outcome of Staphylococcus aureus bloodstream infection.

Authors:  Alexandre R Marra; Michael B Edmond; Betty A Forbes; Richard P Wenzel; Gonzalo M L Bearman
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

6.  Interference of antibiotic therapy on blood cultures time-to-positivity: analysis of a 5-year experience in an oncological hospital.

Authors:  R Passerini; D Riggio; D Radice; L Bava; C Cassatella; M Salvatici; L Zorzino; M T Sandri
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-07-29       Impact factor: 3.267

7.  Microbial and clinical determinants of time-to-positivity in patients with bacteraemia.

Authors:  J A Martínez; L Pozo; M Almela; F Marco; A Soriano; F López; V Balasso; J Aguilar; J Mensa
Journal:  Clin Microbiol Infect       Date:  2007-05-02       Impact factor: 8.067

8.  Correlation between time to positivity of blood cultures with clinical presentation and outcomes in patients with Klebsiella pneumoniae bacteraemia: prospective cohort study.

Authors:  C-H Liao; C-C Lai; M-S Hsu; Y-T Huang; F-Y Chu; H-S Hsu; P-R Hsueh
Journal:  Clin Microbiol Infect       Date:  2009-04-15       Impact factor: 8.067

9.  Time-to-positivity in patients with Escherichia coli bacteraemia.

Authors:  G Peralta; M P Roiz; M B Sánchez; J C Garrido; B Ceballos; M J Rodríguez-Lera; F Mateos; I De Benito
Journal:  Clin Microbiol Infect       Date:  2007-08-29       Impact factor: 8.067

10.  Time to positivity in blood cultures of adults with Streptococcus pneumoniae bacteremia.

Authors:  Galo Peralta; María José Rodríguez-Lera; Jose Carlos Garrido; Luis Ansorena; María Pía Roiz
Journal:  BMC Infect Dis       Date:  2006-04-27       Impact factor: 3.090

  10 in total
  14 in total

1.  Controlled Evaluation of the New BacT/Alert Virtuo Blood Culture System for Detection and Time to Detection of Bacteria and Yeasts.

Authors:  Osman Altun; Mohammed Almuhayawi; Petra Lüthje; Rubina Taha; Måns Ullberg; Volkan Özenci
Journal:  J Clin Microbiol       Date:  2016-02-03       Impact factor: 5.948

Review 2.  Beyond Blood Culture and Gram Stain Analysis: A Review of Molecular Techniques for the Early Detection of Bacteremia in Surgical Patients.

Authors:  Michelle H Scerbo; Heidi B Kaplan; Anahita Dua; Douglas B Litwin; Catherine G Ambrose; Laura J Moore; Col Clinton K Murray; Charles E Wade; John B Holcomb
Journal:  Surg Infect (Larchmt)       Date:  2016-02-26       Impact factor: 2.150

3.  Using Machine Learning To Predict Antimicrobial MICs and Associated Genomic Features for Nontyphoidal Salmonella.

Authors:  Marcus Nguyen; S Wesley Long; Patrick F McDermott; Randall J Olsen; Robert Olson; Rick L Stevens; Gregory H Tyson; Shaohua Zhao; James J Davis
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

4.  Predicting Antimicrobial Resistance and Associated Genomic Features from Whole-Genome Sequencing.

Authors:  Jonathan M Monk
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

5.  Empiric antimicrobial therapy in severe sepsis and septic shock: optimizing pathogen clearance.

Authors:  Stephen Y Liang; Anand Kumar
Journal:  Curr Infect Dis Rep       Date:  2015-07       Impact factor: 3.725

Review 6.  Commercial multiplex technologies for the microbiological diagnosis of sepsis.

Authors:  Evan E Lebovitz; Peter D Burbelo
Journal:  Mol Diagn Ther       Date:  2013-08       Impact factor: 4.074

Review 7.  Use of rapid diagnostic techniques in ICU patients with infections.

Authors:  Almudena Burillo; Emilio Bouza
Journal:  BMC Infect Dis       Date:  2014-11-28       Impact factor: 3.090

8.  Developing an in silico minimum inhibitory concentration panel test for Klebsiella pneumoniae.

Authors:  Marcus Nguyen; Thomas Brettin; S Wesley Long; James M Musser; Randall J Olsen; Robert Olson; Maulik Shukla; Rick L Stevens; Fangfang Xia; Hyunseung Yoo; James J Davis
Journal:  Sci Rep       Date:  2018-01-11       Impact factor: 4.379

9.  Time-to-detection of bacteria and yeast with the BACTEC FX versus BacT/Alert Virtuo blood culture systems.

Authors:  Ali Mohammed Somily; Hanan Ahmed Habib; Armen Albert Torchyan; Samina B Sayyed; Muhammed Absar; Rima Al-Aqeel; A Khalifa Binkhamis
Journal:  Ann Saudi Med       Date:  2018 May-Jun       Impact factor: 1.526

10.  Predicting antimicrobial resistance using conserved genes.

Authors:  Marcus Nguyen; Robert Olson; Maulik Shukla; Margo VanOeffelen; James J Davis
Journal:  PLoS Comput Biol       Date:  2020-10-19       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.